{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:06:41Z","timestamp":1776956801697,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.ejphar.2004.10.051","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T13:07:07Z","timestamp":1103202427000},"page":"133-141","source":"Crossref","is-referenced-by-count":16,"title":["Effects of the mixed-action \u03ba\/\u03bc opioid agonist 8-carboxamidocyclazocine on cocaine- and food-maintained responding in rhesus monkeys"],"prefix":"10.1016","volume":"506","author":[{"given":"Glenn W.","family":"Stevenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark P.","family":"Wentland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean M.","family":"Bidlack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy K.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.10.051_bib1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1124\/jpet.302.1.374","article-title":"8-Carboxamidocyclazocine: a long-acting, novel benzomorphan","volume":"302","author":"Bidlack","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.10.051_bib2","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.npp.1300105","article-title":"Effects of mixed-action kappa\/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys","volume":"28","author":"Bowen","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2004.10.051_bib3","first-page":"1236","article-title":"Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies","volume":"266","author":"Devine","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.10.051_bib4","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2004.10.051_bib5","first-page":"1282","article-title":"Effects of the structurally novel opioid 14 alpha, 14\u2032 beta-[dithiobis [(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) on schedule-controlled behavior and thermal nociception in rhesus monkeys","volume":"278","author":"Gatch","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.10.051_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(95)00306-B","article-title":"Kappa opioid inhibition of morphine and cocaine self-administration in rats","volume":"681","author":"Glick","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2004.10.051_bib7","series-title":"Substance Abuse: A Comprehensive Textbook","first-page":"415","article-title":"Alternative pharmacotherapies for opiate addiction","author":"Greenstein","year":"1997"},{"key":"10.1016\/j.ejphar.2004.10.051_bib8","first-page":"1045","article-title":"Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys","volume":"19","author":"Heath","year":"1984","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2004.10.051_bib9","first-page":"433","article-title":"Effects of ethylketazocine and morphine on schedule-controlled behavior in pigeons and squirrel monkeys","volume":"239","author":"Katz","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2004.10.051_bib10","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1080\/10550490390210083","article-title":"Pharmacologic treatments for heroin and cocaine dependence","volume":"12","author":"Kleber","year":"2003","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.ejphar.2004.10.051_bib11","series-title":"Substance Abuse: A Comprehensive Textbook","first-page":"405","article-title":"Methadone maintenance","author":"Lowinson","year":"1997"},{"key":"10.1016\/j.ejphar.2004.10.051_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(94)90559-2","article-title":"U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats","volume":"181","author":"Maisonneuve","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2004.10.051_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2004.10.051_bib14","first-page":"812","article-title":"Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys","volume":"286","author":"Mello","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.10.051_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2000.tb06678.x","article-title":"Interactions between kappa opioid agonists and cocaine. Preclinical studies","volume":"909","author":"Mello","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2004.10.051_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM199604113341507","article-title":"Management of cocaine abuse and dependence","volume":"334","author":"Mendelson","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2004.10.051_bib17","first-page":"896","article-title":"Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine","volume":"267","author":"Negus","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.10.051_bib18","first-page":"44","article-title":"Effects of kappa opioids on cocaine self-administration by rhesus monkeys","volume":"282","author":"Negus","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.10.051_bib26","series-title":"NIH Publication No. 00-4739A","first-page":"99","article-title":"Epidemiologic trends in drug abuse","year":"2000"},{"key":"10.1016\/j.ejphar.2004.10.051_bib19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2004.10.051_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5694\/j.1326-5377.1994.tb127344.x","article-title":"The transdermal nicotine patch: results of a randomised placebo-controlled trial","volume":"161","author":"Richmond","year":"1994","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.ejphar.2004.10.051_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s002130051016","article-title":"U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking","volume":"144","author":"Schenk","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2004.10.051_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s002130100788","article-title":"Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans","volume":"157","author":"Walsh","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.ejphar.2004.10.051_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0960-894X(01)00014-2","article-title":"8-Carboxamidocyclazocine analogues: redefining the structure-activity relationships of 2,6-methano-3-benzazocines","volume":"11","author":"Wentland","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904012385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904012385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T19:52:02Z","timestamp":1586029922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904012385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0014299904012385"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.10.051","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}